Normal immunoglobulin human 20g/200ml solution for infusion vials
NHS hospitals in England used £81,191,363 of indicative cost of Normal immunoglobulin human 20g/200ml solution for infusion vials in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is down 33.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Normal immunoglobulin human 20g/200ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Normal immunoglobulin human 20g/200ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £5,914,674 |
| Univ Hpl B/Ham Nhs Foundation Trust | £4,949,856 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,084,182 |
| Royal Free London Nhs Foundation Trust | £3,867,534 |
| Sheffield Teaching Hospitals Nhs Trust | £3,222,180 |
| Salford Royal Nhs Foundation Trust | £2,851,308 |
| The Walton Centre Nhs Foundation Trust | £2,774,196 |
| Barts Health Nhs Trust | £2,697,084 |
| King's College Hpl Nhs Foundation Trust | £2,649,348 |
| Nottingham University Hospitals Trust | £2,380,374 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.